Literature DB >> 24873860

Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells.

Kiyosumi Ochi1, Naoya Takayama1, Shoichi Hirose1, Tatsutoshi Nakahata1, Hiromitsu Nakauchi1, Koji Eto2.   

Abstract

Adult hemoglobin composed of α- and β-globin reflects a change from expression of embryonic ε- and fetal γ-globin to adult β-globin in human erythroid cells, so-called globin switching. Human pluripotent stem cells (hPSCs) are a potential source for in vitro erythrocyte production, but they show prominent expression of γ-globin with little β-globin expression, which indicates incomplete globin switching. To examine the mechanism of this impaired globin switching, we optimized multicolor flow cytometry to simultaneously follow expression of different globin subtypes using different immunofluorescent probes. This enabled us to detect upregulation of β-globin and the corresponding silencing of γ-globin at the single-cell level during cord blood CD34(+) cell-derived erythropoiesis, examined as an endogenous control. Using this approach, we initially characterized the heterogeneous β-globin expression in erythroblasts from several hPSC clones and confirmed the predominant expression of γ-globin. These hPSC-derived erythroid cells also displayed reduced expression of BCL11A-L. However, doxycycline-induced overexpression of BCL11A-L in selected hPSCs promoted γ-globin silencing. These results strongly suggest that impaired γ-globin silencing is associated with downregulated BCL11A-L in hPSC-derived erythroblasts and that multicolor staining of globin subtypes is an effective approach to studying globin switching in vitro. ©AlphaMed Press.

Entities:  

Keywords:  BCL11A; Embryonic stem cells; Erythrocyte; Globin switching; iPS cells

Mesh:

Substances:

Year:  2014        PMID: 24873860      PMCID: PMC4073826          DOI: 10.5966/sctm.2013-0216

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  36 in total

Review 1.  The potential of stem cells as an in vitro source of red blood cells for transfusion.

Authors:  Anna Rita Migliaccio; Carolyn Whitsett; Thalia Papayannopoulou; Michel Sadelain
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

2.  "Maturational" globin switching in primary primitive erythroid cells.

Authors:  Paul D Kingsley; Jeffrey Malik; Rachel L Emerson; Timothy P Bushnell; Kathleen E McGrath; Laura A Bloedorn; Michael Bulger; James Palis
Journal:  Blood       Date:  2005-11-01       Impact factor: 22.113

3.  Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells.

Authors:  Kenichi Miharada; Takashi Hiroyama; Kazuhiro Sudo; Toshiro Nagasawa; Yukio Nakamura
Journal:  Nat Biotechnol       Date:  2006-09-17       Impact factor: 54.908

4.  Two mouse early embryonic beta-globin gene sequences. Evolution of the nonadult beta-globins.

Authors:  A Hill; S C Hardies; S J Phillips; M G Davis; C A Hutchison; M H Edgell
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

5.  Hematopoietic colony-forming cells derived from human embryonic stem cells.

Authors:  D S Kaufman; E T Hanson; R L Lewis; R Auerbach; J A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

6.  Large-scale production of embryonic red blood cells from human embryonic stem cells.

Authors:  Emmanuel N Olivier; Caihong Qiu; Michelle Velho; Rhoda Elison Hirsch; Eric E Bouhassira
Journal:  Exp Hematol       Date:  2006-12       Impact factor: 3.084

7.  Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors.

Authors:  Naoya Takayama; Hidekazu Nishikii; Joichi Usui; Hiroko Tsukui; Akira Sawaguchi; Takashi Hiroyama; Koji Eto; Hiromitsu Nakauchi
Journal:  Blood       Date:  2008-04-03       Impact factor: 22.113

8.  Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells.

Authors:  Caihong Qiu; Emmanuel N Olivier; Michelle Velho; Eric E Bouhassira
Journal:  Blood       Date:  2007-11-16       Impact factor: 22.113

9.  Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches.

Authors:  Maria H Ledran; Anna Krassowska; Lyle Armstrong; Ian Dimmick; Jonas Renström; Roland Lang; Sun Yung; Mauro Santibanez-Coref; Elaine Dzierzak; Miodrag Stojkovic; Robert A J Oostendorp; Lesley Forrester; Majlinda Lako
Journal:  Cell Stem Cell       Date:  2008-07-03       Impact factor: 24.633

10.  The WAVE2/Abi1 complex differentially regulates megakaryocyte development and spreading: implications for platelet biogenesis and spreading machinery.

Authors:  Koji Eto; Hidekazu Nishikii; Takunori Ogaeri; Shiro Suetsugu; Akihide Kamiya; Toshihiro Kobayashi; Daisuke Yamazaki; Atsushi Oda; Tadaomi Takenawa; Hiromitsu Nakauchi
Journal:  Blood       Date:  2007-07-30       Impact factor: 22.113

View more
  10 in total

1.  Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia.

Authors:  Alessia Finotti; Monica Borgatti; Roberto Gambari
Journal:  Stem Cell Investig       Date:  2016-10-25

2.  Induced pluripotent stem cell-based mapping of β-globin expression throughout human erythropoietic development.

Authors:  Kim Vanuytsel; Taylor Matte; Amy Leung; Zaw Htut Naing; Tasha Morrison; David H K Chui; Martin H Steinberg; George J Murphy
Journal:  Blood Adv       Date:  2018-08-14

3.  Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease.

Authors:  Naoya Uchida; Juan J Haro-Mora; Atsushi Fujita; Duck-Yeon Lee; Thomas Winkler; Matthew M Hsieh; John F Tisdale
Journal:  Stem Cells       Date:  2016-10-26       Impact factor: 6.277

4.  β-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs.

Authors:  Atsushi Fujita; Naoya Uchida; Juan J Haro-Mora; Thomas Winkler; John Tisdale
Journal:  Stem Cells       Date:  2016-02-24       Impact factor: 6.277

5.  Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.

Authors:  Xiaosong Huang; Ying Wang; Wei Yan; Cory Smith; Zhaohui Ye; Jing Wang; Yongxing Gao; Laurel Mendelsohn; Linzhao Cheng
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

6.  De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.

Authors:  Tsutomu Toki; Kenichi Yoshida; RuNan Wang; Sou Nakamura; Takanobu Maekawa; Kumiko Goi; Megumi C Katoh; Seiya Mizuno; Fumihiro Sugiyama; Rika Kanezaki; Tamayo Uechi; Yukari Nakajima; Yusuke Sato; Yusuke Okuno; Aiko Sato-Otsubo; Yusuke Shiozawa; Keisuke Kataoka; Yuichi Shiraishi; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Kiminori Terui; Tomohiko Sato; Takuya Kamio; Hirotoshi Sakaguchi; Shouichi Ohga; Madoka Kuramitsu; Isao Hamaguchi; Akira Ohara; Hitoshi Kanno; Satoru Miyano; Seiji Kojima; Akira Ishiguro; Kanji Sugita; Naoya Kenmochi; Satoru Takahashi; Koji Eto; Seishi Ogawa; Etsuro Ito
Journal:  Am J Hum Genet       Date:  2018-08-23       Impact factor: 11.025

Review 7.  Recent trends in the gene therapy of β-thalassemia.

Authors:  Alessia Finotti; Laura Breda; Carsten W Lederer; Nicoletta Bianchi; Cristina Zuccato; Marina Kleanthous; Stefano Rivella; Roberto Gambari
Journal:  J Blood Med       Date:  2015-02-19

8.  Lent-On-Plus Lentiviral vectors for conditional expression in human stem cells.

Authors:  Karim Benabdellah; Pilar Muñoz; Marién Cobo; Alejandra Gutierrez-Guerrero; Sabina Sánchez-Hernández; Angélica Garcia-Perez; Per Anderson; Ana Belén Carrillo-Gálvez; Miguel G Toscano; Francisco Martin
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

9.  Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model.

Authors:  Nungruthai Nilsri; Panchalee Jangprasert; Jaturawat Pawinwongchai; Nipan Israsena; Ponlapat Rojnuckarin
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 10.  Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies.

Authors:  Ponthip Pratumkaew; Surapol Issaragrisil; Sudjit Luanpitpong
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.